Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
2(33%)
Results Posted
100%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_3
1
17%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution1 total trials
Phase 3Large-scale testing
1(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Recruiting2
Completed1
Not yet recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (100.0%)

Trials by Status

completed117%
not_yet_recruiting117%
recruiting233%
terminated117%
unknown117%

Recent Activity

2 active trials
Showing 5 of 6
not_yet_recruiting

Assessment of D-dimer and CRP for Cardiovascular Risk Prediction in Hemodialysis Patients

NCT07130721
terminated

ThRombosis ExclUsion STudy

NCT03477968
recruiting

AQT90 FLEX D-dimer Clinical Sensitivity and Specificity

NCT06749223
completed

National Early Warning Score and D-dimer to Identify Medical Patients At Low Risk of 30-day Mortality

NCT03108807
recruiting

Role of Preoperative D-dimer Levels in the Diagnosis of Adnexal Torsion

NCT06324565
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07130721

Assessment of D-dimer and CRP for Cardiovascular Risk Prediction in Hemodialysis Patients

Not Yet Recruiting
NCT03477968

ThRombosis ExclUsion STudy

Terminated
NCT06749223

AQT90 FLEX D-dimer Clinical Sensitivity and Specificity

Recruiting
NCT03108807

National Early Warning Score and D-dimer to Identify Medical Patients At Low Risk of 30-day Mortality

Completed
NCT06324565

Role of Preoperative D-dimer Levels in the Diagnosis of Adnexal Torsion

Recruiting
NCT04802382Phase 3

Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
6